Login / Signup

Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries.

Eloisa Rubio-BeltránKa Yi ChanAh Jan DanserAntoinette MaassenVanDenBrinkLars Edvinsson
Published in: Cephalalgia : an international journal of headache (2019)
ubrogepant and atogepant differentially inhibit the calcitonin gene-related peptide-dependent vasodilatory responses in intracranial arteries when compared to distal human coronary arteries. Also, both gepants are devoid of vasoconstrictive properties in human coronary arteries.
Keyphrases